
Oxetol300 mg
Sun Pharmaceutical Ltd.
Oxcarbazepine is an anticonvulsant (antiepileptic) medicine indicated for the treatment of partial-onset (focal) seizures.
Oxcarbazepine is an anticonvulsant (antiepileptic) medicine indicated for the treatment of partial-onset (focal) seizures.
Use of Oxcarbazepine for any indication should be guided and monitored by a physician.
Initial dose: 300 mg twice daily. May be increased by up to 300 mg/day every third day to a target dose of 1200 mg/day, based on clinical response.
Initial dose: 300 mg twice daily, added to existing therapy. Increase by a maximum of 600 mg/day at approximately weekly intervals,to an achieved daily dose of 600-2400 mg/day, as needed and tolerated.
| Use | Dosing approach |
|---|---|
| Adjunctive therapy | Weight-based starting dose (approximately 8-10 mg/kg/day divided twice daily), titrated over about 2 weeks to a weight-based maintenance dose (higher mg/kg doses for lower body weights), as advised by the treating physician. |
| Monotherapy | Weight-based initial and maintenance dosing similar in principle to adjunctive therapy, individualized by the physician. |
In patients with creatinine clearance less than 30 mL/min, therapy should be started at half the usual starting dose (300 mg/day) with slower titration, due to reduced clearance of the active metabolite.
Oxcarbazepine can be taken with or without food. Do not stop Oxcarbazepine abruptly without medical advice, as this can increase the risk of seizures; dose reduction should be gradual (tapered) when discontinuing.
Common side effects of Oxcarbazepine include:
Hyponatremia (low blood sodium) is a notable and relatively common side effect of Oxcarbazepine, more so than with many other anticonvulsants; it can occasionally be severe (see Precautions and Warnings).
Serious but less common side effects that require prompt medical attention include serious skin reactions (see Precautions and Warnings), multi-organ hypersensitivity reactions, and mood/behavioral changes including suicidal thoughts.
Oxcarbazepine is contraindicated in patients with a known hypersensitivity to Oxcarbazepine or to any of its excipients.
Because Oxcarbazepine is chemically related to carbamazepine, patients who have had a hypersensitivity reaction to carbamazepine should be aware that cross-hypersensitivity to Oxcarbazepine occurs in a notable proportion of such patients (approximately one in four); Oxcarbazepine should not be used in patients with known hypersensitivity to carbamazepine unless the potential benefit is judged by the physician to outweigh the risk, with close monitoring.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.